Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Cert. of designation
Appointed director
|
|
Bionik Laboratories Corp. (BNKL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2022 |
10-K
| Annual Report for the period ended March 31, 2022 |
| 06/24/2021 |
10-K
| Annual Report for the period ended March 31, 2021 |
| 06/29/2020 |
10-K
| Annual Report for the period ended March 31, 2020 |
| 07/01/2019 |
10-K
| Annual Report for the period ended March 31, 2019 |
| 06/27/2018 |
10-K
| Annual Report for the period ended March 31, 2018 |
| 06/29/2017 |
10-K
| Annual Report for the period ended March 31, 2017 |
| 06/30/2016 |
10-KT
| Form 10-KT - Transition reports [Rule 13a-10 or 15d-10] |
| 03/18/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
| 05/27/2015 |
10-KT
| Form 10-KT - Transition reports [Rule 13a-10 or 15d-10] |
| 04/15/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
| 04/15/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
| 03/06/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
| 04/10/2012 |
10-K
| Annual Report for the period ended December 31, 2011 |
|
|